FI840260A7 - Pyrrolidinonijohdannaiset ja menetelmä niiden valmistamiseksi. - Google Patents

Pyrrolidinonijohdannaiset ja menetelmä niiden valmistamiseksi.

Info

Publication number
FI840260A7
FI840260A7 FI840260A FI840260A FI840260A7 FI 840260 A7 FI840260 A7 FI 840260A7 FI 840260 A FI840260 A FI 840260A FI 840260 A FI840260 A FI 840260A FI 840260 A7 FI840260 A7 FI 840260A7
Authority
FI
Finland
Prior art keywords
preparation
pyrrolidinone derivatives
pyrrolidinone
derivatives
Prior art date
Application number
FI840260A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI840260L (fi
FI840260A0 (fi
Inventor
Bruno Kamber
Angelo Storni
William Bencze
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI840260A0 publication Critical patent/FI840260A0/fi
Publication of FI840260A7 publication Critical patent/FI840260A7/fi
Publication of FI840260L publication Critical patent/FI840260L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI840260A 1983-01-27 1984-01-23 Pyrrolidinonderivat och foerfarande foer deras framstaellning. FI840260L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH45383 1983-01-27

Publications (3)

Publication Number Publication Date
FI840260A0 FI840260A0 (fi) 1984-01-23
FI840260A7 true FI840260A7 (fi) 1984-07-28
FI840260L FI840260L (fi) 1984-07-28

Family

ID=4187370

Family Applications (1)

Application Number Title Priority Date Filing Date
FI840260A FI840260L (fi) 1983-01-27 1984-01-23 Pyrrolidinonderivat och foerfarande foer deras framstaellning.

Country Status (12)

Country Link
EP (1) EP0115472A3 (OSRAM)
JP (1) JPS59141559A (OSRAM)
KR (1) KR840007571A (OSRAM)
AU (1) AU2383884A (OSRAM)
DD (1) DD216005A5 (OSRAM)
DK (1) DK35884A (OSRAM)
FI (1) FI840260L (OSRAM)
GR (1) GR81746B (OSRAM)
IL (1) IL70772A0 (OSRAM)
NO (1) NO840310L (OSRAM)
PT (1) PT78007B (OSRAM)
ZA (1) ZA84560B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943625C (de) * 1943-06-28 1956-05-24 Ferguson Harry Inc Seitensteuerungseinrichtung fuer ein landwirtschaftliches Schlepperanbaugeraet
JPH0696574B2 (ja) * 1987-09-16 1994-11-30 三菱化成株式会社 ４−ピペリジンカルボキサミド誘導体
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
JP2997488B2 (ja) * 1989-12-25 2000-01-11 興研株式会社 腫瘍細胞増殖抑制剤
CA2172125A1 (en) * 1993-09-30 1995-04-06 S. Jane Desolms Inhibitors of farnesyl-protein transferase
EP1159273A1 (en) 1999-03-02 2001-12-05 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
TW201206425A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Treatment of depressive disorders
EP1915145A1 (en) 2005-07-29 2008-04-30 Blanchette Rockefeller Neurosciences Institute Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
EP3332797A3 (en) 2007-02-09 2018-08-01 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs and other related substances on head trauma-induced memory impairment and brain injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins
GB1539817A (en) * 1976-10-22 1979-02-07 Ucb Sa N-substituted lactams

Also Published As

Publication number Publication date
PT78007A (en) 1984-02-01
DK35884D0 (da) 1984-01-26
IL70772A0 (en) 1984-04-30
DD216005A5 (de) 1984-11-28
FI840260L (fi) 1984-07-28
NO840310L (no) 1984-07-30
EP0115472A2 (de) 1984-08-08
PT78007B (en) 1986-06-18
KR840007571A (ko) 1984-12-08
DK35884A (da) 1984-07-28
JPS59141559A (ja) 1984-08-14
AU2383884A (en) 1984-08-02
FI840260A0 (fi) 1984-01-23
EP0115472A3 (de) 1985-10-02
ZA84560B (en) 1984-09-26
GR81746B (OSRAM) 1984-12-12

Similar Documents

Publication Publication Date Title
FI862210A7 (fi) Imidatsoheterosykliset yhdisteet ja menetelmä niiden valmistamiseksi.
FI873180A7 (fi) Uudet hetratsepiinit ja menetelmä niiden valmistamiseksi.
FI830704A7 (fi) Kefalosporiinijohdannaiset ja menetelmä niiden valmistamiseksi.
ZA847755B (en) Pyrrolidinone derivatives
FI810511A7 (fi) Kefalosporiinijohdannaisia ja menetelmä niiden valmistamiseksi.
FI820839A7 (fi) Uusia 3,4-dihydro-5H-2,3- bentsodiatsepiinijohdannaisia ja menetelmä niiden valmistamiseksi.
FI843933A7 (fi) Kefalosporiinijohdannaiset ja menetelmä niiden valmistamiseksi.
FI852796A7 (fi) Uudet pyrimidiinijohdannaiset, menetelmä niiden valmistamiseksi ja näitä sisältävät seokset.
FI840260A7 (fi) Pyrrolidinonijohdannaiset ja menetelmä niiden valmistamiseksi.
FI811703A7 (fi) Uusia kinoksalin-2-yyli-etenyyliketoneja ja menetelmä niiden valmistamiseksi.
FI863480A7 (fi) Atsolyyli-syklopropyyli -etanolijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö.
FI850266A7 (fi) Atsolyyliaryylialkanolijohdoksia, menetelmä niiden valmistamiseksi ja niiden käyttö.
FI814197A7 (fi) Menetelmä kiteisen tuotteen valmistamiseksi ja käyttämiseksi.
FI802903A7 (fi) Nitrosoureajohdannaisia ja menetelmä niiden valmistamiseksi.
FI840588A7 (fi) N-sulfenyloidut hydantoiinit, menetelmä niiden valmistamiseksi ja niiden käyttö mikrobisideinä.
FI840610A7 (fi) Bentsopyraani-johdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältävä pestisidinen koostumus.
AU560725B2 (en) Pyrrolidinone derivatives
FI885665A7 (fi) Menetelmä raemaisen detergenttiaineen valmistamiseksi ja näin saatu raemainen detergenttiaine
FI820876A7 (fi) 2-bentsoyyliamino-substituoidut bentsyyliamiinijohdosket ja menetelmä niiden valmistamiseksi.
FI844675A7 (fi) Substituoituja bentsopentatiepiinejä, menetelmä niiden valmistamiseksi ja siinä käytettäviä väliyhdisteitä.
FI813374A7 (fi) 4-tia-PGI1 ja sulfinyyli-PGI1 ja näiden johdannaiset ja menetelmä näiden valmistamiseksi.
KR860004851A (ko) 피롤리딘 유도체의 제조방법
FI854595A7 (fi) 1,4-dihydropyridiinejä, menetelmä niiden valmistamiseksi ja niiden käyttö.
PT78008B (en) Process for preparing substituted pyrrolidinone derivatives
FI821361A7 (fi) Uusia 13-tiaprostasykliini-johdannaisia ja menetelmä niiden valmistamiseksi.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: CIBA-GEIGY AG